BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17430270)

  • 1. Ipsilateral right testicular metastasis from renal cell carcinoma in a responder patient to interleukine-2 treatment.
    Camerini A; Tartarelli G; Martini L; Donati S; Puccinelli P; Amoroso D
    Int J Urol; 2007 Mar; 14(3):259-60. PubMed ID: 17430270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contralateral solitary testis metastasis antedating renal cell carcinoma: a case-report and review.
    Lauro S; Lanzetta G; Bria E; Trasatti L; Costarelli L; Vecchione A
    Anticancer Res; 1998; 18(6B):4683-4. PubMed ID: 9891540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solitary delayed contralateral testicular metastasis from renal cell carcinoma.
    Nabi G; Gania MA; Sharma MC
    Indian J Pathol Microbiol; 2001 Oct; 44(4):487-8. PubMed ID: 12035375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Paratesticular recurrence of renal carcinoma].
    Márquez Moreno AJ; Machuca Santa Cruz J; Corral García P; Jiménez Martín J; Ortega Jiménez MV; Polo Camacho M
    Arch Esp Urol; 2001 Dec; 54(10):1135-7. PubMed ID: 11852526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of renal cell carcinoma found after skin metastasis.
    Mitsuhashi M; Kiyota A; Yoshimura R; Matsuyama M; Nakatani T; Wada S; Ito S; Yoshimoto M; Funao K; Kobayakawa H; Nakao N; Nakae A
    Hinyokika Kiyo; 2004 Apr; 50(4):239-43. PubMed ID: 15188615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete response in a cutaneous facial metastatic nodule from renal cell carcinoma after hypofractionated radiotherapy.
    Gay HA; Cavalieri R; Allison RR; Finley J; Quan WD
    Dermatol Online J; 2007 Oct; 13(4):6. PubMed ID: 18319003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Will we be able to "cure" metastatic renal cell carcinoma like we cure testicular tumours?
    Kirkali Z
    Eur Urol; 2008 Oct; 54(4):712-4. PubMed ID: 18640767
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful sorafenib treatment for metastatic renal cell carcinoma in a case with chronic renal failure.
    Ruppin S; Protzel C; Klebingat KJ; Hakenberg OW
    Eur Urol; 2009 Apr; 55(4):986-8; quiz 988. PubMed ID: 19004541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy.
    Ramsey S; Aitchison M
    J Urol; 2005 Dec; 174(6):2422-3. PubMed ID: 16280863
    [No Abstract]   [Full Text] [Related]  

  • 11. Biomarkers of therapeutic response in melanoma and renal cell carcinoma: potential inroads to improved immunotherapy.
    Kirkwood JM; Tarhini AA
    J Clin Oncol; 2009 Jun; 27(16):2583-5. PubMed ID: 19364958
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma.
    Bennouna J; Bompas E; Neidhardt EM; Rolland F; Philip I; Galéa C; Salot S; Saiagh S; Audrain M; Rimbert M; Lafaye-de Micheaux S; Tiollier J; Négrier S
    Cancer Immunol Immunother; 2008 Nov; 57(11):1599-609. PubMed ID: 18301889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orbital metastasis of renal cell carcinoma masquerading as cysticercosis.
    Preechawai P; Amrith S; Yip CC; Goh KY
    Orbit; 2008; 27(5):370-3. PubMed ID: 18836935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance biotherapy with interleukin-2 and interferon for metastatic renal cell cancer.
    Porta C
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):141-52. PubMed ID: 16375651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-related acute lung injury (TRALI) following platelet transfusion in a patient receiving high-dose interleukin-2 for treatment of metastatic renal cell carcinoma.
    Medeiros BC; Kogel KE; Kane MA
    Transfus Apher Sci; 2003 Aug; 29(1):25-7. PubMed ID: 12877889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of pemphigus vulgaris associated with interleukin 2 therapy.
    Prussick R; Plott RT; Stanley JR
    Arch Dermatol; 1994 Jul; 130(7):890-3. PubMed ID: 7794299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Testicular metastasis and local recurrence of renal cell carcinoma after nephron-sparing surgery in von Hippel-Lindau disease].
    Nemoto K; Shimizu H; Kimura G
    Hinyokika Kiyo; 2007 Mar; 53(3):163-5. PubMed ID: 17447484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple pancreatic metastases from clear cell renal carcinoma: diagnosis with chemical shift magnetic resonance imaging before surgery.
    Koyama H; Maruta T; Kudo T; Mayahara H; Yoshida K
    Australas Radiol; 2005 Dec; 49(6):493-6. PubMed ID: 16351615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
    Samlowski WE; Majer M; Boucher KM; Shrieve AF; Dechet C; Jensen RL; Shrieve DC
    Cancer; 2008 Nov; 113(9):2539-48. PubMed ID: 18780316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 based immunotherapy in patients with metastatic renal cell carcinoma.
    Donskov F
    Dan Med Bull; 2007 Nov; 54(4):249-65. PubMed ID: 18208677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.